American Healthcare (AHR) analyst forecast and price target
Analyst forecast
Consensus of 16 analyst ratings
Based on 10 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $60.00 from $66.00 | Oct 13, 2026 |
| Raymond James | Initiated Coverage | Strong Buy | $62.00 | Oct 13, 2026 |
| UBS | Maintained | Buy | $62.00 from $63.00 | Oct 13, 2026 |
| Scotiabank | Maintained | Sector Outperform | $62.00 from $56.00 | Sep 2, 2026 |
| Barclays | Maintained | Overweight | $66.00 from $61.00 | Aug 31, 2026 |
| Keybanc | Maintained | Overweight | $68.00 from $58.00 | Aug 19, 2026 |
| RBC Capital | Maintained | Outperform | $61.00 from $56.00 | Aug 14, 2026 |
| Truist Securities | Maintained | Buy | $61.00 from $57.00 | Aug 14, 2026 |
| Citigroup | Maintained | Buy | $65.00 from $55.00 | Aug 13, 2026 |
| Citizens | Maintained | Market Outperform | $65.00 from $60.00 | Jul 27, 2026 |
| Compass Point | Initiated Coverage | Buy | $70.00 | Jul 21, 2026 |
| UBS | Maintained | Buy | $63.00 from $60.00 | Jul 8, 2026 |
| Barclays | Initiated Coverage | Overweight | $61.00 | Jul 7, 2026 |
| Citigroup | Upgraded | Neutral → Buy | $55.00 | Jun 23, 2026 |
| Scotiabank | Maintained | Sector Outperform | $51.00 from $59.00 | Jun 18, 2026 |
| Keybanc | Maintained | Overweight | $58.00 from $55.00 | May 28, 2026 |
| RBC Capital | Maintained | Outperform | $56.00 from $54.00 | May 26, 2026 |
| Truist Securities | Maintained | Buy | $57.00 from $52.00 | Mar 13, 2026 |
| Scotiabank | Maintained | Sector Outperform | $59.00 from $55.00 | Mar 11, 2026 |
| Citigroup | Maintained | Neutral | $55.00 from $52.00 | Mar 2, 2026 |
Frequently asked questions
What is the price target for AHR stock?
The average 12-month analyst price target for American Healthcare (AHR) is $63.60, with a high estimate of $70.00 and a low of $60.00, across 10 analysts.
Is AHR a buy, sell, or hold?
Analysts covering American Healthcare currently average a Buy rating: 16 buy, 0 hold and 0 sell, from 16 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for AHR?
The average price target of $63.60 implies 21.33% upside from the last price of $52.42.
What is the latest analyst rating on AHR?
On Oct 13, 2026, Barclays maintained American Healthcare at Overweight with a price target of $60.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.